Introduction
The tooth is a complex organ that consists of enamel, dentin, cementum, and pulp. Missing teeth is frequently occurring problem in aging populations. To treat these defects, the current approach involves prostheses, autotransplantation, and dental implants. The exploration of new strategies for tooth replacement has become a hot topic. Using the foundations of experimental embryology, developmental and molecular biology, tooth regeneration is becoming realistic possibility. Several different methods have been proposed to achieve biological tooth replacement. These include scaffold-based tooth regeneration, cell pellet engineering, stimulation of the formation of a third dentition, and gene-manipulated tooth regeneration. The idea that a third dentition might be locally induced to replace missing teeth is an attractive concept (Young et al., 2005; Edward & Mason, 2006; Takahashi et al., 2008 Takahashi et al., , 2013 ). This approach is generally presented in terms of adding molecules to induce de novo tooth initiation in the mouth. Tooth development is the result of reciprocal and reiterative signaling between oral ectoderm-derived dental epithelium and cranial neural crest cellderived dental mesenchyme under genetic control (Thesleff, 2006) . More than 200 genes are known to be expressed during tooth development (http://bite-it.helsinki.fi/). A number of mouse mutants are now starting to provide some insights into the mechanisms of supernumerary tooth formation. Multiple supernumerary teeth may have genetic components in their etiology and partially represent the third dentition in humans. Such candidate molecules might be those that are involved in embryonic tooth induction, in successional tooth formation, or in the control of the number of teeth. This means that it may be possible to induce de novo tooth formation by the in situ repression or activation of a single candidate molecule. In this review, we provide an overview of the collective knowledge of tooth regeneration, especially regarding the control of the number of teeth for molecularly targeted therapy by the stimulation of a third dentition.
The third dentition
It has been suggested that, in humans, a "third dentition" with one or more supernumerary teeth can occur in addition to the permanent dentition, and supernumerary teeth are sometimes thought to represent a partial post-permanent dentition (Ooe, 1969) . The deciduous teeth are, ontogenetically, the first generation of teeth. The permanent teeth (except molar) belong to the second dentition. The term "third dentition" refers to the opinion that one more set of teeth can occur in addition to the permanent teeth ( Figure 1 ). Human teeth are diphyodont excepting the permanent molars. The normal mouse dentition is monophyodont and composed of one incisor and three molars in each quadrant. The number of teeth is usually strictly determined. It was initially reported that there is an anlagen of the third dentition in some mammals (Leche, 1893) . The presence of an epithelial anlagen of the third dentition was also noticed in humans (Ooe, 1969) . The teeth and anlagen that appear in third dentition in serial sections of infant jaws and some fetuses have been analysed. The epithelium which is considered as the anlagen of the third dentition develops lingual to all permanent tooth germs (Ooe, 1969) . Furthermore, when it appears, the predecessor (permanent tooth germ) is in the bellshaped stage (Ooe, 1969) . The timing of appearance of the third dentition seems to be after birth (Table 1 ). This means that we have a chance to access the formation of the third dentition in the mouth.
Detailed histological analysis of the tooth replacement in these models indicates that the successional teeth are initiated from the dental lamina epithelium, which grows from the lingual side of the deciduous tooth enamel organ, and it later elongates and buds into the jaw mesenchyme, forming successional teeth. Jarvien et al. showed that, in the ferret, Usag-1(also known as Sostdc1, Ectodin, and Wise) is expressed in the elongating successional dental lamina at the interface between the lamina and deciduous tooth, as well as the buccal side of the dental lamina, suggesting that Sostdc1 plays a role in defining the identity of the dental lamina(Jarvinen et al., 2009). Handrigan et al. analysed successional tooth formation in the snake and in lizard, and proposed that dental epithelium stem cells are responsible for the formation of successional lamina, and Wnt signaling may regulate the dental eithelial stem cell fate in these cells (Handrigan et al., 2010) . Maintenance or reactivation of component dental lamina is thus pivotal for the replacement tooth and supernumerary formation.
Human syndromes associated with supernumerary teeth
Supernumerary teeth can be associated with a syndrome or they can be found in nonsyndromic patients. Only 1% of non-syndromic cases have multiple supernumerary teeth, which occur most frequently in the mandibular premolar area, followed by the molar and anterior regions, respectively (Yusof, 1990 ; Yague-Garcia et al., 2009). Genetic mutations have been associated with the presence or absence of individual types of teeth.
Supernumerary teeth are associated with 8 syndromes and developmental abnormalities in which the resposible genes already have been isolated . The percentage occurrence in CCD is 22% in the maxillary incisor region and 5% in the molar region (Shafer, 1983) . CCD is a dominantly inherited skeletal dysplasia caused by mutations in RUNX2 . There is a wide spectrum of phenotypic variability ranging from the full-blown phenotype to an isolated dental phenotype characterized by supernumerary tooth formation and/or the delayed eruption of permanent teeth in CCD . Runx2-deficient mice were found to exhibit lingual buds in front of the upper molars, and these were much more prominent than in wild-type mice (Aberg et al., 2004) . These buds presumably represent the mouse secondary dentition, and it is likely that RUNX2 acts to prevent the formation of these buds. Runx2 regulates the proliferation of cells and may exert specific control on the dental lamina and formation of successive dentitions. Runx2 heterozygous mutant mice mostly phenocopied the skeletal defects of CCD in humans, but with no supernumerary tooth formation . Notably, in Runx2 homozygous and heterozygous mouse upper molars, a prominent epithelial bud regularly presents. This epithelial bud protrudes lingually with active Shh signaling, and it may represent the extension of the dental lamina for successional tooth formation in mice. Hence, although Runx2 is required for primary tooth development, it prevents the growth of the dental lamina and successional tooth formation (Otto et al., 1997).
Familial adenomatous polyposis (FAP), also named adenomatous polyposis of the colon (APC), is an autosomal dominant hereditary disorder characterized by the development of many precancerous colorectal adenomatous polyps. In addition to colorectal neoplasm, individuals can develop variable extracolonic lesions, including upper gastrointestinal polyposis, osteomas and dental anomalies (Wijn et al., 2007) . Dental abnormalities include impacted teeth, congenital absence of one or more teeth, supernumerary teeth and odontomas (Wijn et al., 2007) . Gardner syndrome is a variant of FAP characterized by multiple adenomas of the colon and rectum typical of FAP together with osteomas and soft tissue tumors (Chimenos-Kustner et al., 2005). Supernumerary teeth and osteomas were originally described as a part of Gardner syndrome, but they can also occur in FAP patients with or without other extracolonic lesions (Chimenos-Kustner et al., 2005; Wijn et al., 2007). FAP and Gardner syndrome are caused by a large number of germinal mutations in the Apc gene (Groden et al., 1991) . Apc is a tumor suppressor gene involved in the down-regulation of free intracellular ß-catenin, the major signal transducer of the canonical Wnt signaling pathway (Groden et al., 1991) . Approximately 11-27% of patients have supernumerary teeth, but, so far, no specific codon mutation of the Apc gene has been found to correlate with supernumerary teeth.
The identification of mutations in RUNX2 causing an isolated dental phenotype in CCD and in Apc causing FAP has attracted attention as a possible route towards inducing de novo tooth formation. . These results support our interpretation that USAG-1 functions as a novel BMP-7 antagonist in the maxilla. We confirmed that increased BMP signaling in supernumerary teeth of the USAG-1 deficient mice could be prohibited by BMP-7 abrogation. In the contrast, to test whether BMP-7 has the potential to induce supernumerary tooth formation, we performed explant culture and subsequent subrenal kidney capsule culture. The incisor explants supplemented with BMP-7 in USAG-1 (Huysseune et al., 2004) . In young mice, supernumerary tooth germs were induced in multiple regions of the jaw in both incisor and molar regions. They can form directly from the oral epithelium, in the dental lamina connecting the developing molar or incisor tooth germ to the oral epithelium, in the crown region, as well as in the elongating and furcation area of the developing root (Wang et al., 2009 ). Wnt/BMP signaling seems to be essential in supernumerary tooth formation (Figure 3 ).
Supernumerary tooth formation in a mouse model
We also demonstrated that Cebpb deficiency was related to the formation of supernumerary teeth (Figure 2) . A total of 66.7% of Cebpb -/-12-month-olds sustained supernumerary teeth and/ or odontomas in the diastema between the incisor and the first molar (Huang et al., 2012) . Furthermore, it was suggested that the dental epitheilal stem cells might be contributated to supernumerary tooth formation in mice (Figure 2) .
These mouse models clearly demonstrated that it was possible to induce de novo tooth formation by the in situ inhibition or activation of single molecule such as USAG-1, BMP7 or CEBPB.
Molecularly targeted therapy
Molecularly targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific types of cells by interfering with specific targeted molecules.
Most targeted therapies are either small moleclule or monoclonal antibodies. Small molecules are typically able to diffuse into cells and can act on target that are found inside the cells. Monoclonal antibodies usually can not penetorate the surface membrane and are directed against targets that are outside cells or on the surface of cells. Candidates for small molecules are identified in screeing the effect of thousands of test compounds on a specific target. The best candidates are then chemically modified to produce many closely related versions. Monoclonal antibody are prepared first by immunized animals such as mice with purified target moleclules.They are humanized by replacing the animal portion of the antibody with human portion. More than 40 molecularly targeted cancer therapy have been approved by the U.S Food and Drug Administration for the treatment of specific type of cancer. Many more are in clinical trials or preclinical testing (Forscher et al., 2014) . Recent molecularly targeted therapy also has successfully been introduced into the treatment of several inflammatory rheumatic diseases such as rheumatoid arthritis (Mocsai et al., 2014).
Molecularly targeted therapy provides a unique tool for the delivery of previously identified signaling molecules in both time and space that may significantly augment our progress toward clinical tooth regeneration. Stimulation of the formation of a third dentition comprises an attractive concept (Figure 4 ). This approach is generally presented in terms of adding molecules to induce de novo tooth initiation in the mouth. We have a chance to access the formation of the third dentition in the mouth, because the time of appearance of the third dentition seems to be after birth. Advances in our understanding of signal transduction by Wnt/BMP signalling in the supernumerary teeth formation offer numerous opportunities for devising new targeted therapies (Figure 3) .This led to a new approach of drug development whereby targeted therapy are developed by directly targeting molecules thought to be involved in the the formation of a third dentition. A mojor approach for the development targeted therapeutics has been the application of monoclonal antibody for targeting molecules such as USAG-1.
Molecularly targeted therapy seems to be a suitable approach in tooth regeneration by stimulation of the third dentition. The third dentition develops lingual to the permanent tooth germ (D). All impacted supernumerary teeth in this patient are located to the lingual side of the permanent teeth (white arrow) (A-C). These multiple supernumerary teeth seem to be post-permanent dentition ("third dentition"). Underlined molecules are responsible genes for human syndromes or mutant mouse associated with supernumerary teeth 
Conclusion
We have a chance to access the formation of the third dentition in the mouth, because the timing of the appearance of the third dentition seems to be after birth. The identification of mutations in RUNX2 causing an isolated dental phenotype in CCD and supernumerary tooth formation in the mouse model clearly demonstrated that it was possible to induce de novo tooth formation by the in situ inhibition or activation of a single candidate molecule. These results support the idea that the de novo inhbition or activation of candidate molecules such as RUNX2 or USAG-1 might be used to stimulate the third dentition in order to induce new tooth formation in the mouse (Figure 4 ). Molecularly targeted therapy seems to be a suitable approach in tooth regeneration by stimulation of the third dentition.
